AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11577619 — intervention group
Group type: EXPERIMENTAL
Intervention: Plausibility-enhancing manipulation (reading accounts of the occurrence of events) combined with personalized suggestion
Number of subjects: 0
Study 11577619 — intervention group
Group type: COMPARATOR
Intervention: Plausibility manipulation alone
Number of subjects: 0
Study 9614159 — intervention group
Group type: EXPERIMENTAL
Intervention: Skim milk + bifidobacteria
Number of subjects: 0
Study 9614159 — intervention group
Group type: COMPARATOR
Intervention: Skim milk alone
Number of subjects: 0
Study 8305412 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin alone or in combination with fish oil concentrate
Number of subjects: 14
Study 8305412 — intervention group
Group type: COMPARATOR
Intervention: Normolipemic control subjects
Number of subjects: 14
Study 8305412 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial hypercholesterolemia patients
Number of subjects: 14
Study 2846479 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron radiotherapy
Number of subjects: 32
Study 2846479 — intervention group
Group type: COMPARATOR
Intervention: Photon radiotherapy
Number of subjects: 32
Study 31815643 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 days of antibiotic prophylaxis
Number of subjects: 270
Study 31815643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 28601506 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal sex education
Number of subjects: 145
Study 28601506 — intervention group
Group type: EXPERIMENTAL
Intervention: Kegel exercises
Number of subjects: 145
Study 28601506 — intervention group
Group type: COMPARATOR
Intervention: Routine postmenopausal care
Number of subjects: 145
Study 26370445 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate ≤65 bpm
Number of subjects: 2812
Study 26370445 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting heart rate >65 bpm
Number of subjects: 2812
Study 24175487 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis users
Number of subjects: 73
Study 24175487 — intervention group
Group type: EXPERIMENTAL
Intervention: Female cannabis users
Number of subjects: 73
Study 24175487 — intervention group
Group type: COMPARATOR
Intervention: Non-users
Number of subjects: 73
Study 22006873 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective left colectomy for colon cancer (CC)
Number of subjects: 1721
Study 22006873 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective left colectomy for diverticular disease (DD)
Number of subjects: 1721
Study 19765502 — intervention group
Group type: EXPERIMENTAL
Intervention: LHW+ME
Number of subjects: 1100
Study 19765502 — intervention group
Group type: COMPARATOR
Intervention: ME
Number of subjects: 1100
Study 17680654 — intervention group
Group type: EXPERIMENTAL
Intervention: Telaprevir alone
Number of subjects: 16
Study 17680654 — intervention group
Group type: EXPERIMENTAL
Intervention: Telaprevir + pegylated interferon-alpha-2a (PEG-IFN-alpha-2a)
Number of subjects: 16
Study 17680654 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG-IFN-alpha-2a and ribavirin after 14-day dosing period
Number of subjects: 16
Study 15153324 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm
Number of subjects: 37614
Study 15153324 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 37614
Study 11510709 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin 2,500 iu, subcutaneously once daily for four or five days post-operatively
Number of subjects: 76
Study 11510709 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo), subcutaneously once daily for four or five days post-operatively
Number of subjects: 76
Study 9300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative low dose radiotherapy (5 x 2 Gy; total: 10 Gy)
Number of subjects: 410
Study 9300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative medium dose radiotherapy (5 x 3.5 Gy; total: 17.5 Gy)
Number of subjects: 410
Study 9300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (1 x 7 Gy)
Number of subjects: 410
Study 9300751 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (5 x 3.5 Gy; total: 17.5 Gy)
Number of subjects: 410
Study 9300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis of preoperative group with ipsilateral Brooker Grade III and IV ossification
Number of subjects: 410
Study 9300751 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional failures in HOP 1
Number of subjects: 410
Study 9300751 — intervention group
Group type: COMPARATOR
Intervention: Functional failures in HOP 2
Number of subjects: 410
Study 8327418 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized risk invitation
Number of subjects: 2076
Study 8327418 — intervention group
Group type: COMPARATOR
Intervention: General risk invitation
Number of subjects: 2076
Study 8327418 — intervention group
Group type: COMPARATOR
Intervention: No risk factor questionnaire + generic invitation
Number of subjects: 2076
Study 8327418 — intervention group
Group type: COMPARATOR
Intervention: No risk factor questionnaire + general risk invitation
Number of subjects: 2076
Study 8327418 — intervention group
Group type: COMPARATOR
Intervention: Risk factor questionnaire + general risk invitation
Number of subjects: 2076
Study 8327418 — intervention group
Group type: COMPARATOR
Intervention: Risk factor questionnaire + personal risk invitation
Number of subjects: 2076
Study 3733491 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal emotional words presented to the right visual field
Number of subjects: 0
Study 3733491 — intervention group
Group type: COMPARATOR
Intervention: Subliminal neutral words
Number of subjects: 0
Study 3733491 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal emotional words
Number of subjects: 0
Study 31390891 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring data
Number of subjects: 463
Study 28749095 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil concentration 2 ng/mL
Number of subjects: 30
Study 28749095 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil concentration 6 ng/mL
Number of subjects: 30
Study 27209482 — intervention group
Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 49
Study 27209482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 24366103 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine (500-mg capsules taken orally up to 2 capsules 3 times per day)
Number of subjects: 75
Study 24366103 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 24030274 — intervention group
Group type: EXPERIMENTAL
Intervention: AAQ
Number of subjects: 100
Study 24030274 — intervention group
Group type: EXPERIMENTAL
Intervention: AAQ + AMX
Number of subjects: 100
Study 24030274 — intervention group
Group type: COMPARATOR
Intervention: Pre-intervention
Number of subjects: 100
Study 20650452 — intervention group
Group type: EXPERIMENTAL
Intervention: EGD plus EUS
Number of subjects: 172
Study 20650452 — intervention group
Group type: COMPARATOR
Intervention: EGD plus TUS
Number of subjects: 172
Study 20650452 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS
Number of subjects: 172
Study 20650452 — intervention group
Group type: EXPERIMENTAL
Intervention: EGD with standard, forward‐viewing endoscope
Number of subjects: 172
Study 20650452 — intervention group
Group type: EXPERIMENTAL
Intervention: EGD with oblique‐viewing echoendoscope
Number of subjects: 172
Study 19112800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional photothermolysis treatment
Number of subjects: 20
Study 16650421 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose methotrexate (MTX)
Number of subjects: 108
Study 16650421 — intervention group
Group type: COMPARATOR
Intervention: Multiple-dose methotrexate (MTX)
Number of subjects: 108
Study 12785439 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the gluteus maximus for 1 hour a day, 6 days a week for 8 weeks
Number of subjects: 22
Study 12785439 — intervention group
Group type: COMPARATOR
Intervention: Control group (no extra treatment)
Number of subjects: 22
Study 11769843 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic nephrectomy
Number of subjects: 24
Study 11769843 — intervention group
Group type: COMPARATOR
Intervention: Retroperitoneal laparoscopic nephrectomy
Number of subjects: 24
Study 9174562 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg daily) + Pindolol (7.5 mg daily)
Number of subjects: 111
Study 9174562 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg daily) + Placebo
Number of subjects: 111
Study 8230572 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal renal angioplasty (PTRA)
Number of subjects: 58
Study 8230572 — intervention group
Group type: COMPARATOR
Intervention: Surgical reconstruction
Number of subjects: 58
Study 3778162 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.5-mm lateral borehole drilled into the femoral shaft
Number of subjects: 26
Study 3778162 — intervention group
Group type: COMPARATOR
Intervention: Control group without boreholes
Number of subjects: 26
Study 29782196 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac sodium
Number of subjects: 99
Study 29782196 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dexamethasone
Number of subjects: 99
Study 29782196 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical fluorometholone
Number of subjects: 99
Study 29782196 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 99
Study 26447668 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18134
Study 26447668 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18134
Study 24783198 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight support treadmill training (BWSTT)
Number of subjects: 0
Study 22373729 — intervention group
Group type: EXPERIMENTAL
Intervention: FFC-AL (function-focused care intervention)
Number of subjects: 0
Study 22373729 — intervention group
Group type: COMPARATOR
Intervention: FFC-education only (attention control)
Number of subjects: 0
Study 21041914 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir (ATV/RTV; 300/100 mg once daily)
Number of subjects: 252
Study 21041914 — intervention group
Group type: COMPARATOR
Intervention: Unboosted atazanavir (ATV; 400 mg once daily)
Number of subjects: 252
Study 21041914 — intervention group
Group type: EXPERIMENTAL
Intervention: Unboosted atazanavir (ATV)
Number of subjects: 252
Study 21041914 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted atazanavir (ATV/RTV)
Number of subjects: 252
Study 18489496 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotic medication
Number of subjects: 421
Study 16808310 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO therapy (5000 IU 2 times per week s.c. for 4 months)
Number of subjects: 22
Study 16808310 — intervention group
Group type: COMPARATOR
Intervention: Clinical observation (no rHuEPO therapy)
Number of subjects: 22
Study 11133641 — intervention group
Group type: EXPERIMENTAL
Intervention: Vital Heat plus cotton blanket
Number of subjects: 7
Study 11133641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton blanket
Number of subjects: 7
Study 11133641 — intervention group
Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 7
Study 9755009 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative garment and textile system
Number of subjects: 66
Study 9755009 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative clothing system
Number of subjects: 66
Study 9755009 — intervention group
Group type: EXPERIMENTAL
Intervention: Clean air suits and impermeable patient drapes
Number of subjects: 66
Study 7829283 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory STM
Number of subjects: 68
Study 7829283 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal STM
Number of subjects: 68
Study 7829283 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory LTM
Number of subjects: 68
Study 7829283 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal LTM
Number of subjects: 68
Study 3389898 — intervention group
Group type: EXPERIMENTAL
Intervention: High sodium preterm formula
Number of subjects: 347
Study 3389898 — intervention group
Group type: COMPARATOR
Intervention: Low sodium preterm formula
Number of subjects: 347
Study 1473323 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime NPH insulin
Number of subjects: 12
Study 1473323 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning NPH insulin
Number of subjects: 12
Study 1473323 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (baseline)
Number of subjects: 12
Study 354829 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 155
Study 31154306 — intervention group
Group type: EXPERIMENTAL
Intervention: m-health intervention 'SWAP IT Childcare' for 4 months
Number of subjects: 18
Study 31154306 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 18
Study 28512278 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine monolayer collagen matrix (mCM) with an envelope flap left coronally uncovered
Number of subjects: 27
Study 28512278 — intervention group
Group type: COMPARATOR
Intervention: Porcine monolayer collagen matrix (mCM) with a coronally repositioned flap covered by mucosa
Number of subjects: 27
Study 26360837 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2C9*1/*3 group
Number of subjects: 52
Study 26360837 — intervention group
Group type: COMPARATOR
Intervention: CYP2C9*1/*1 group
Number of subjects: 52
Study 26360837 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP2D6*10
Number of subjects: 52
Study 23426412 — intervention group
Group type: EXPERIMENTAL
Intervention: Retapamulin 1% applied twice daily for 5 days
Number of subjects: 508
Study 23426412 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment applied twice daily for 5 days
Number of subjects: 508
Study 23426412 — intervention group
Group type: EXPERIMENTAL
Intervention: Retapamulin 1%
Number of subjects: 508
Study 23426412 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 508
Study 21339244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-free procedures on low-prime, surface-coated extracorporeal circuitry (FX05, Terumo)
Number of subjects: 80
Study 21339244 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-free procedures with standard uncoated circuitry (D902, Sorin)
Number of subjects: 80
Study 21339244 — intervention group
Group type: COMPARATOR
Intervention: Control - procedures requiring Tx on uncoated circuitry
Number of subjects: 80
Study 19393841 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day buprenorphine patches (5, 10, and 20 microg/h, maximum dosage of 20 microg/h)
Number of subjects: 134
Study 19393841 — intervention group
Group type: COMPARATOR
Intervention: Prolonged-release tramadol tablets (75, 100, 150, and 200 mg, maximum dosage of 400 mg/d)
Number of subjects: 134
Study 19393841 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day buprenorphine patches
Number of subjects: 134
Study 19393841 — intervention group
Group type: COMPARATOR
Intervention: Prolonged-release tramadol tablets
Number of subjects: 134
Study 16572288 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondral defect scores (femoral and patellar)
Number of subjects: 371
Study 16572288 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary CTX-II
Number of subjects: 371
Study 16572288 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI and osteophytes
Number of subjects: 371
Study 16572288 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI and biochemical measures
Number of subjects: 371
Study 15080361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant containing fluorosilicate glass (Helioseal‐F)
Number of subjects: 18
Study 15080361 — intervention group
Group type: EXPERIMENTAL
Intervention: Sealant containing methacryloyl fluoride‐methyl methacrylate copolymer (Teethmate‐F)
Number of subjects: 18
Study 15080361 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Helioseal‐F and Teethmate‐F)
Number of subjects: 18
Study 11430634 — intervention group
Group type: EXPERIMENTAL
Intervention: Budipine 10 mg single dose
Number of subjects: 18
Study 11430634 — intervention group
Group type: EXPERIMENTAL
Intervention: Budipine 10 mg t.i.d for 10 days
Number of subjects: 18
Study 11430634 — intervention group
Group type: COMPARATOR
Intervention: Budipine 20 mg single dose
Number of subjects: 18
Study 11430634 — intervention group
Group type: COMPARATOR
Intervention: Budipine 30 mg single dose
Number of subjects: 18
Study 9623435 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifrontal montage
Number of subjects: 0
Study 9623435 — intervention group
Group type: COMPARATOR
Intervention: Fronto-central montage
Number of subjects: 0
Study 7839462 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intra-arterial mitomycin-C (10 mg/m2 in 500 ml normal saline over 6 hours)
Number of subjects: 20
Study 7839462 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative intra-arterial mitomycin-C
Number of subjects: 20
Study 7839462 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery alone)
Number of subjects: 20
Study 3284340 — intervention group
Group type: EXPERIMENTAL
Intervention: norfloxacin (400 mg every 12 hours)
Number of subjects: 63
Study 3284340 — intervention group
Group type: COMPARATOR
Intervention: cotrimoxazole (160/800 mg every 12 hours)
Number of subjects: 63
Study 30578013 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of intravenous (IV) amoxicillin‐clavulanate TID
Number of subjects: 78
Study 30578013 — intervention group
Group type: COMPARATOR
Intervention: 50 mL of IV 0.9% NaCl TID (placebo)
Number of subjects: 78
Study 28925502 — intervention group
Group type: COMPARATOR
Intervention: No-antibiotic regimen with supportive care (intravenous fluids, analgesia, and antipyretics as necessary)
Number of subjects: 245
Study 28925502 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day course of antibiotics with supportive care
Number of subjects: 245
Study 28925502 — intervention group
Group type: COMPARATOR
Intervention: No-antibiotic regimen with supportive care
Number of subjects: 245
Study 26612447 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal ultrathin endoscopy
Number of subjects: 61
Study 26612447 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopy
Number of subjects: 61
Study 26612447 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 24220555 — intervention group
Group type: EXPERIMENTAL
Intervention: CO-101
Number of subjects: 367
Study 24220555 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 367
Study 24220555 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine (high hENT1 subgroup)
Number of subjects: 367
Study 21701333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal avotermin (200 ng/100 μl/linear cm wound margin)
Number of subjects: 60
Study 21701333 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal avotermin
Number of subjects: 60
Study 21701333 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19114324 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin bolus infusion before ERCP followed by continuous infusion for 12 hours
Number of subjects: 133
Study 19114324 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin bolus before ERCP only
Number of subjects: 133
Study 19114324 — intervention group
Group type: COMPARATOR
Intervention: Control group (no somatostatin treatment)
Number of subjects: 133
Study 16490019 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual counseling and PGE1-intracavernous injection (ICI) therapy (SC+)
Number of subjects: 57
Study 16490019 — intervention group
Group type: COMPARATOR
Intervention: Only PGE1-intracavernous injection (ICI) therapy (SC-)
Number of subjects: 57
Study 14555866 — intervention group
Group type: EXPERIMENTAL
Intervention: Early treatment with antidepressants (started within the first month after stroke)
Number of subjects: 62
Study 14555866 — intervention group
Group type: COMPARATOR
Intervention: Late treatment with antidepressants (started after 1 month)
Number of subjects: 62
Study 11148431 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum chewing for 1 hour after the meal
Number of subjects: 36
Study 11148431 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking for 1 hour after the meal
Number of subjects: 36
Study 11148431 — intervention group
Group type: COMPARATOR
Intervention: Standard breakfast
Number of subjects: 36
Study 9623385 — intervention group
Group type: EXPERIMENTAL
Intervention: 22G polyurethane cannula
Number of subjects: 144
Study 9623385 — intervention group
Group type: COMPARATOR
Intervention: 23G silicone cannula
Number of subjects: 144
Study 7868799 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy (RT) only
Number of subjects: 37
Study 7868799 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) and Chemotherapy (CT)
Number of subjects: 37
Study 7868799 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (RT and CT)
Number of subjects: 37
Study 7868799 — intervention group
Group type: COMPARATOR
Intervention: Cranial irradiation
Number of subjects: 37
Study 3149764 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintained nicotine cigarette
Number of subjects: 21
Study 3149764 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle tar cigarette
Number of subjects: 21
Study 3149764 — intervention group
Group type: COMPARATOR
Intervention: Low tar cigarette
Number of subjects: 21
Study 31596449 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular surgery
Number of subjects: 60703
Study 31596449 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractures surgery
Number of subjects: 60703
Study 31596449 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal operations
Number of subjects: 60703
Study 28857119 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimorbidity (Charlson Comorbidity Index (CCI) score)
Number of subjects: 381
Study 28857119 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher symptom burden
Number of subjects: 381
Study 25795339 — intervention group
Group type: EXPERIMENTAL
Intervention: Overnight fasting
Number of subjects: 20
Study 25795339 — intervention group
Group type: COMPARATOR
Intervention: Elevated glucose condition
Number of subjects: 20
Study 25795339 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior cognitive effort
Number of subjects: 20